Evidence map›Paper›PMID 29991652›Full record

ArticleJournal of lipid research2018

Circulating HDL levels control hypothalamic astrogliosis via apoA-I.

Anna Götz, Maarit Lehti, Elizabeth Donelan, Cynthia Striese, Sebastian Cucuruz, Stephan Sachs, Chun-Xia Yi, Stephen C Woods, Samuel D Wright, Timo D Müller and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 5 countries.

Anna GötzInstitutes for Diabetes and Obesity Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany; Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany.
Maarit LehtiLIKES Research Centre for Physical Activity and Health, Jyväskylä, Finland.
Elizabeth DonelanMetabolic Disease Institute, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH.
Cynthia StrieseDiabetes and Regeneration Research, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Sebastian CucuruzDiabetes and Regeneration Research, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Stephan SachsDiabetes and Regeneration Research, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Chun-Xia YiDepartment of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Stephen C WoodsMetabolic Disease Institute, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH.
Samuel D WrightCSL Behring, King of Prussia, PA.
Timo D MüllerInstitutes for Diabetes and Obesity Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
Matthias H TschöpInstitutes for Diabetes and Obesity Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
Yuanqing GaoNanjing Medical University, College of Pharmacy, Nanjing, China. Electronic address: yuanqinggao@njmu.edu.cn.
Susanna M HofmannGerman Center for Diabetes Research (DZD), München-Neuherberg, Germany; Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilian Universität, Munich, Germany. Electronic address: susanna.hofmann@helmholtz-muenchen.de.
Deutsches Diabetes-Zentrum e.V. · DEHelmholtz Zentrum München · DEUniversity of Cincinnati · USCSL (United States) · USLIKES – Foundation for Sport and Health Sciences · FINanjing Medical University · CNRWTH Aachen University · DEUniversity of Amsterdam · NL

Funding

Ohio Interdisciplinary Women's Health Career TrainingK12HD051953 · NICHD · UNIVERSITY OF CINCINNATI · PI TSEVAT, JOEL · 2005 to 2014
$4.2M
NICHD NIH HHS K12 HD051953
6 · The paper itself

Abstract

Meta-inflammation of hypothalamic areas governing energy homeostasis has recently emerged as a process of potential pathophysiological relevance for the development of obesity and its metabolic sequelae. The current model suggests that diet-induced neuronal injury triggers microgliosis and astrocytosis, conditions which ultimately may induce functional impairment of hypothalamic circuits governing feeding behavior, systemic metabolism, and body weight. Epidemiological data indicate that low circulating HDL levels, besides conveying cardiovascular risk, also correlate strongly with obesity. We simulated that condition by using a genetic loss of function mouse model (apoA-I

Indexed as

Adenosine TriphosphateAnimalsApolipoprotein A-IAstrocytesBiomarkersGliosisGlycolysisHypothalamusLipoproteins, HDLMaleMiceMice, Inbred C57BLMitochondriaOxidative PhosphorylationPhenotypeAdenosine TriphosphateApolipoprotein A-IBiomarkersLipoproteins, HDLadipose tissueapolipoprotein A-Iastrocytesdyslipidemiahigh density lipoproteinhypothalamusinflammationmetabolismmitochondria

Identifiers

PMID29991652
PMCPMC6121940
OpenAlexW2839584865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.